Working capital / assets moved 1181 bp lower
Working capital / assets changed -1181 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital / assets changed -1181 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +716 basis points from the comparable as-filed period.
Free-cash-flow proxy changed +36.5% from the comparable as-filed period.
Current ratio changed -16.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating cash flow changed +23.5% from the comparable as-filed period.
Total assets changed +58.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current liabilities changed +36.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
SBC / revenue changed -467 basis points from the comparable as-filed period.
Operating income changed +604.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Capital expenditure changed -72.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +10.4% from the comparable as-filed period.
R&D / revenue changed -367 basis points from the comparable as-filed period.
Current long-term debt changed -25.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Receivables / revenue changed +353 basis points from the comparable as-filed period.
Free-cash-flow margin changed +263 basis points from the comparable as-filed period.
Capex / revenue changed -113 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed +13.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed -26.8% from the comparable as-filed period.
Trade receivables changed +16.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed -6.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Research & development changed -5.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed +3.6% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
Operating cash-flow margin changed +151 basis points from the comparable as-filed period.
Reported total debt changed -12.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross debt changed -12.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Debt / revenue changed -23 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Debt / assets changed -14 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Debt changed -62.4% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Free-cash-flow proxy changed +72.9% from the comparable as-filed period.
Operating margin changed +799 basis points from the comparable as-filed period.
Operating cash flow changed +61.1% from the comparable as-filed period.
SBC / revenue changed -451 basis points from the comparable as-filed period.
Revenue changed +12.9% from the comparable as-filed period.
Operating income changed +305.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Cash & equivalents changed -15.9% from the comparable as-filed period.
Net income changed +175.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Research & development changed -11.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capital expenditure changed +23.0% from the comparable as-filed period.
Stock-based compensation changed -21.3% from the comparable as-filed period.
Capex / revenue changed +27 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.